David Savoie
Psychiatric/Mental Health · Lafayette, LANPI 1356098842
Payments from drug & device makers
Across 112 payments — averaging $27.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$552
- Braeburn Inc.$467
- Alkermes, Inc.$437
- AbbVie$377
- Axsome Therapeutics, Inc.$295
- Indivior Inc.$238
- plus $729 from 11 others
What the payments were for
- Food & beverage$3,094100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $552 |
| Braeburn Inc. | 19 | $467 |
| Alkermes, Inc. | 18 | $437 |
| AbbVie | 18 | $377 |
| Axsome Therapeutics, Inc. | 11 | $295 |
| Indivior Inc. | 8 | $238 |
| E.r. Squibb & Sons, L.L.C. | 2 | $147 |
| Vanda Pharmaceuticals Inc. | 4 | $124 |
| Theratechnologies Inc. | 3 | $120 |
| Gilead | 1 | $112 |
| EMD Serono, Inc. | 4 | $104 |
| Johnson & Johnson | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| Exact Sciences | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Corium, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$500
- SUBLOCADE$126
- VRAYLAR$125
- REXULTI$123
- COBENFY$122
- ABILIFY MAINTENA$121
- ABILIFY ASIMTUFII$121
- Auvelity$118
- BRIXADI$113
- Epclusa$112
How this compares
$3,094 in reported general payments places this provider in the 70th percentile of 615 psychiatric/mental health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 13 | $83 |
| Fluoxetine Hcl | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Lafayette
- Melissa GuilbeauLafayette$122K
- Bryant DronetteLafayette$17K
- Cinderella BroussardLafayette$14K
- Lore Lyndsey MoranLafayette$12K
- Danielle ThreattsLafayette$11K
- Seth WoodruffLafayette$10K
- Latonya WoodsLafayette$10K
- Laura KightLafayette$9K
- Amy LacoutureBaton Rouge$663K
- Amanda EymardHouma$617K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.